Assessing Bio-Rad Laboratories after recent performance Bio-Rad Laboratories (BIO) has attracted attention after a mixed stretch of returns, with the stock roughly flat over the past year but showing ...

Discover the leading players and innovations shaping the global biosensors market with the "Biosensors Companies Quadrant" report by 360 Quadrants. This comprehensive industry analysis evaluates over ...

Project Atlas employs numerous genetic modifications operating in tandem to create an entirely new class of materials. The ...

Rad's (BIO) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.

Today, we will review the fourth quarter and full year 2025 financial results and provide an update on key business trends ...

Bio-Rad Laboratories (BIO) came out with quarterly earnings of $2.51 per share, missing the Zacks Consensus Estimate of $2.57 per share. This compares to earnings of $2.9 per share a year ago. These ...

HERCULES, Calif. (AP) — HERCULES, Calif. (AP) — Bio-Rad Laboratories Inc. (BIO.B) on Thursday reported fourth-quarter net income of $720 million, after reporting a loss in the same period a year ...

Bio-Rad Laboratories missed estimated earnings by -5.28%, reporting an EPS of $2.51 versus an estimate of $2.65. Revenue was up $25.70 million from the same period last year. In the previous quarter, ...